Cancer Care Companion

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT07278778
Status
Recruiting

Conditions

  • Pediatric Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cancer Care Companion — OTHER
    The investigators will provide parents access the Cancer Care Companion through Epic MyChart. If a participant has not enrolled in MyChart, the investigator will provide instructional materials and assist with registration. Parents will use the Cancer Care Companion for 3 months during which they will complete tasks including educational modules, check-in surveys, and patient stories. Participants may opt-out of receiving the patient stories. During the 3-month intervention, participants will receive 13 educational tasks, 7 check-in surveys, and 5 patient stories (if requested). The Day 1 educational task will include an overview of the program and further instructions. After enrollment, participants will retain access to Cancer Care Companion for at least 3 months, during which they can revisit the content.

Study Details

This study invites parents of children with cancer to use an electronic health record (EHR)-based communication tool, called the Cancer Care Companion, and assess the acceptability, appropriateness, and feasibility of the tool.

Key Dates

Start date
Feb 4, 2026
Status verified
Feb 2026
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: All Participants
    All participants receive the Cancer Care Companion program. There is no control or comparison group.

Primary Outcome Measure

Tool feasibility [ Time Frame: Immediately post-intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University School of Medicine/Saint Louis Children's HospitalSt LouisMissouri63110
Bryan Sisk, MD, MSCI
314-454-6018
Bryan Sisk, MD, MSCI (PRINCIPAL_INVESTIGATOR)
Maura Kepper, Ph.D. (SUB_INVESTIGATOR)
Albert Lai, Ph.D. (SUB_INVESTIGATOR)
Anna Kerr, Ph.D. (SUB_INVESTIGATOR)

Find similar trials in St Louis, MO

Related Studies